Headlines

Eli Lilly (LLY) says its obesity pill, Zepbound, significantly reduced the severity of obstructive sleep apnea in patients with obesity in a late-stage trial

Newsquawk Staff ·

Eli Lilly (LLY) says its obesity pill, Zepbound, significantly reduced the severity of obstructive sleep apnea in patients with obesity in a late-stage trial.

Related headlines